Skip to content
June 5, 2025
  • HOME
  • NKY COMMUNITY CALENDAR
  • OBITUARIES
  • CONTACT US
  • WHO WE ARE
  • COMMUNITY ENGAGEMENT
NKyTribune

NKyTribune

Northern Kentucky's Newspaper

NKyCVB Slider
CVG
R.C.Durr Foundation
St. Elizabeth
BE-NKY
Duke Energy
previous arrow
next arrow
1

Category Collection

Business3890 News
Education3804 News
Government4109 News
Health3487 News
Living3945 News
News4450 News
NonProfit3632 News
Our Rich History500 News
Region/State3976 News
Sports7942 News
Voices3560 News
  • Business
  • Education
  • Government
  • Health
  • Living
  • News
  • NonProfit
  • Region/State
  • Sports
  • Voices
Home » Lenzilumab

Lenzilumab

  • Health
  • News Ticker

CTI, Humanigen Inc. dose first COVID-19 patient with FDA-approved lenzilumab proprietary antibody

May 8, 2020May 7, 20200

Covington’s CTI partner, Humanigen Inc., has announced that the first COVID-19 patient has been dosed with its FDA-approved proprietary antibody…

Read More
  • Business
  • News Ticker

Covington-based CTI partners with Humanigen for study of Lenzilumab for treatment of Coronavirus

March 31, 2020March 30, 20200

Covington-based CTI Clinical Trial and Consulting Services has partnered with California-based Humanigen, Inc. on a study for the treatment of novel…

Read More
Facebook Twitter ConstantContact
Donation bug

Archives

Affiliations

• Institute for Nonprofit News
• Online News Association
• N. Ky. Chamber of Commerce
• Covington Business Council
© 2024 Kentucky Center for Public Service Journalism. All rights reserved.
  • Business
  • Education
  • Government
  • Health
  • Living
  • News
  • NonProfit
  • Region/State
  • Sports
  • Voices